Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Short

Showing results (21-30 of 346) with videos related to

Pageof 35
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|September 25, 2021
SOHO State of the Art Updates & Next Questions: Intensive and Non-Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNicholas J Short, Hagop Kantarjian, Elias Jabbour
Expert Review of Hematology|May 10, 2024
Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?Nicholas J Short, Hagop Kantarjian, Elias Jabbour
Leukemia & Lymphoma|June 8, 2024
Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimensNicholas J Short, Hagop Kantarjian, Elias Jabbour
Leukemia & Lymphoma|March 31, 2022
Hyperleukocytosis and leukostasis in acute and chronic leukemiasWalid Macaron, Zaven Sargsyan, Nicholas J Short
Cancer|October 21, 2017
Reply to ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemiaNicholas J Short, Hagop Kantarjian, Elias Jabbour
Clinical Lymphoma, Myeloma & Leukemia|March 14, 2024
SOHO State of the Art Updates and Next Questions, Measurable Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNicholas J Short, Elias Jabbour, Hagop Kantarjian
Leukemia|June 26, 2021
Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigmsNicholas J Short, Hagop Kantarjian, Elias Jabbour
Current Hematologic Malignancy Reports|August 31, 2023
An Update on the Management of Advanced Phase Chronic Myeloid LeukemiaNicholas J Short, Jayastu Senapati, Elias Jabbour
Blood Cancer Journal|September 11, 2023
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitorsNicholas J Short, Daniel Nguyen, Farhad Ravandi
The American Journal of the Medical Sciences|March 30, 2011
Intra-abdominal splenosis mimicking metastatic cancerNicholas J Short, Teresa G Hayes, Peeyush Bhargava
Pageof 35

Showing results (21-30 of 346) with videos related to

Sort By:
Pageof 35
Clinical Lymphoma, Myeloma & Leukemia|September 25, 2021
SOHO State of the Art Updates & Next Questions: Intensive and Non-Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNicholas J Short, Hagop Kantarjian, Elias Jabbour
Expert Review of Hematology|May 10, 2024
Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?Nicholas J Short, Hagop Kantarjian, Elias Jabbour
Leukemia & Lymphoma|June 8, 2024
Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimensNicholas J Short, Hagop Kantarjian, Elias Jabbour
Leukemia & Lymphoma|March 31, 2022
Hyperleukocytosis and leukostasis in acute and chronic leukemiasWalid Macaron, Zaven Sargsyan, Nicholas J Short
Cancer|October 21, 2017
Reply to ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemiaNicholas J Short, Hagop Kantarjian, Elias Jabbour
Clinical Lymphoma, Myeloma & Leukemia|March 14, 2024
SOHO State of the Art Updates and Next Questions, Measurable Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNicholas J Short, Elias Jabbour, Hagop Kantarjian
Leukemia|June 26, 2021
Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigmsNicholas J Short, Hagop Kantarjian, Elias Jabbour
Current Hematologic Malignancy Reports|August 31, 2023
An Update on the Management of Advanced Phase Chronic Myeloid LeukemiaNicholas J Short, Jayastu Senapati, Elias Jabbour
Blood Cancer Journal|September 11, 2023
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitorsNicholas J Short, Daniel Nguyen, Farhad Ravandi
The American Journal of the Medical Sciences|March 30, 2011
Intra-abdominal splenosis mimicking metastatic cancerNicholas J Short, Teresa G Hayes, Peeyush Bhargava
Pageof 35